Finally, we present a case study of the use of caCORRECT to reliably identify biomarkers for renal cell carcinoma, yielding two diagnostic biomarkers with potential clinical utility, PRKAB1 and NNMT. The gene discussed is PRKAB1; the disease is hereditary clear cell renal cell carcinoma.